Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer Effect on GLP-1 and Glucose Homeostasis
NCT02061124Completed
- Sponsor
- Gentofte Hospital
- Start
- Feb 2014
- Primary completion
- Oct 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sevelamer carbonate in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Gentofte Hospital. Primary endpoint: Incremental and total area under the Concentration-Time Curve. Started Feb 2014; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02061124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061124.